Abiopharma

News list

Director CARNAHAN KAREN L 🟢 acquired 134 shares (1 derivative) of CINTAS CORP (CTAS) Transaction Date: Jul 28, 2026 | Filing ID: 011493

Full text

News bot July 30, 2026, 10:19 p.m.
🔍 CARNAHAN KAREN L (Director)

Company: CINTAS CORP (CTAS)

Report Date: 2026-07-28
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 134
Detailed Transactions and Holdings:
- Acquired 134 shares of Phantom Stock Units (Derivative)
  Date: 2026-07-28 | Code: A | equity_swap_involved: 0 | shares_owned_after: 6,815.81 | transaction_form_type: 4 | Footnotes: F1, F1, F1
Footnotes:
- F1: Reporting Person elected to defer a portion of the Reporting Person's cash retainer fees into Phantom Stock Units pursuant to the Directors' Deferred Compensation Plan (including dividend equivalents that have been credited as additional Phantom Stock Units), each unit having a value equal to one share of Cintas Corporation common stock but are not actual shares of common stock and carry no voting rights. Phantom Stock Units are payable only in cash after termination of service as a director.